Skip to content
ANAVEX
ANAVEX
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US
Search
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US
View allAlzheimer's DiseaseAnavex2-73EventsNews ReleasesPDDPIPELINEPressRett Syndrome
Aug72017

Money 1 1120 x 480

Anavex Reports Fiscal Third Quarter 2017 Financial Results

August 7, 2017
Jul202017

Anavex Life Sciences Appoints Distinguished Researcher in Neurology and Epilepsy to Scientific Advisory Board

July 20, 2017

2017 Bio International Convention June 19-22

June 16, 2017
Jun52017

Anavex Life Sciences to Present at Jefferies 2017 Global Healthcare Conference

June 5, 2017

Jefferies 2017 Global Healthcare Conference June 6-9

May 30, 2017

Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome − Data Presented at Antiepileptic Drug Trials XIV 2017 Conference

May 22, 2017
May222017

Multiple sclerosis

Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome − Data Presented at Antiepileptic Drug Trials XIV 2017 Conference −

May 22, 2017
May172017

Anavex President & CEO Christopher U. Missling, PhD, to present preclinical data on ANAVEX 2-73™ at the Epilepsy Foundation’s Antiepileptic Drug Trials XIV Conference on May 19.

May 17, 2017
May102017

Money 1 1120 x 480

Anavex Reports Fiscal Second Quarter 2017 Financial Results

May 10, 2017
May12017

Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs

May 1, 2017

Anavex President & CEO Christopher U. Missling, PhD, to participate in a roundtable discussion at the World Orphan Drug Congress USA, on April 21.

April 21, 2017
Apr32017

Anavex Life Sciences Reports New Mechanism of Action Data Related to ANAVEX Compounds Targeting Sigma-1 Receptor

April 3, 2017
1
234567
…89101112…
1314151617181920212223242526272829303132333435363738394041
42

ANAVEX® is a trademark of Anavex®Life Sciences Corp. - 2019 All Rights Reserved

Go to Top